Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Ashwin Jaikumarr RamSmiline Girija AsVijayashree Priyadharsini JayaseelanPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
These findings suggest that BASP1 was frequently amplified which contributes to the overexpression of BASP1, thereby promoting HNSCC progression. Thus, these results indicate that BASP1 might serve as a biomarker to predict the progression and prognosis of HNSCC patients.